A carregar...
Drugs for improving esophageal mucosa defense: where are we now and where are we going?
In the past, the attention of physiologists and doctors has been mainly focused on the key role of acid in the pathogenesis of gastroesophageal reflux disease (GERD), but increasing evidence that 20-40% of reflux patients respond not at all or only partially to proton pump inhibitors (PPIs) has unde...
Na minha lista:
| Publicado no: | Ann Gastroenterol |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Hellenic Society of Gastroenterology
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5670277/ https://ncbi.nlm.nih.gov/pubmed/29118552 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.20524/aog.2017.0187 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|